TD Waterhouse Canada’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.32M Buy
41,105
+12,256
+42% +$2.54M 0.02% 302
2025
Q4
$5.93M Sell
28,849
-908
-3% -$181K 0.04% 256
2025
Q3
$5.5M Sell
29,757
-4,865
-14% -$829K 0.04% 262
2025
Q2
$5.61M Sell
34,622
-2,098
-6% -$334K 0.04% 259
2025
Q1
$6.04M Sell
36,720
-592
-2% -$103K 0.05% 234
2024
Q4
$6.17M Buy
37,312
+6,578
+21% +$1.12M 0.05% 235
2024
Q3
$5.28M Sell
30,734
-40
-0.1% -$6.62K 0.04% 250
2024
Q2
$4.72M Sell
30,774
-368
-1% -$55.2K 0.04% 249
2024
Q1
$4.93M Buy
+31,142
New +$4.75M 0.04% 254

Other funds holding FBT

TD Waterhouse Canada's FBT Position: Q1 2026 in Review

TD Waterhouse Canada increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 42% in Q1 2026, buying an estimated $2.54M and bringing the position to 41,105 shares worth $8.32M. The position accounts for 0.02% of the portfolio, ranked #302.

TD Waterhouse Canada first reported a position in FBT in Q1 2024 and has held it in 9 quarters since. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • TD Waterhouse Canada held 41,105 shares of First Trust NYSE Arca Biotechnology Index Fund worth $8.32M as of Q1 2026.
  • TD Waterhouse Canada bought 12,256 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $2.54M.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of TD Waterhouse Canada's portfolio in Q1 2026, its #302 holding.
  • TD Waterhouse Canada first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2024 and has held it in 9 quarters since.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.